Biofrontera (BFRI) Receivables - Other (2020 - 2025)

Biofrontera's Receivables - Other history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• On a quarterly basis, Receivables - Other fell 9.43% year-over-year to $4.8 million in Q4 2025; TTM through Dec 2025 was $4.8 million, a 9.43% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 9.43% from the prior year.
• Receivables - Other rose to $4.8 million in Q4 2025 per BFRI's latest filing, from $200000.0 in the prior quarter.
• Across five years, Receivables - Other topped out at $8.7 million in Q1 2022 and bottomed at $56000.0 in Q3 2021.
• The 5-year median for Receivables - Other is $3.4 million (2022), against an average of $3.4 million.
• Across the five-year window, Receivables - Other surged 10792.86% in 2022 and plunged 95.44% in 2024, its largest moves.
• Year by year, Receivables - Other stood at $100000.0 in 2021, then surged by 6400.0% to $6.5 million in 2022, then plunged by 56.92% to $2.8 million in 2023, then soared by 89.29% to $5.3 million in 2024, then dropped by 9.43% to $4.8 million in 2025.
• Per Business Quant, the three latest BFRI Receivables - Other figures stand at $4.8 million (Q4 2025), $200000.0 (Q1 2025), and $5.3 million (Q4 2024).